Parker Albert P Insider Trades

Insider Trading History

Track insider trading activity for Parker Albert P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $362k 278,333 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 85,000 shares
$1.30
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Oct 10, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$260k 200,000 shares
$1.30
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $251k 193,333 shares
Last Trade
Oct 10, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$43.8k 33,685 shares
$1.30
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $295k 227,018 shares
Last Trade
Feb 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.71k 3,173 shares
$0.54
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $299k 230,191 shares
Last Trade
Feb 08, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.28k 5,463 shares
$0.60
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $306k 235,654 shares
Last Trade
Feb 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8k 18,864 shares
$0.63
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $282k 216,790 shares
Last Trade
Feb 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.5k 5,841 shares
$0.60
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $289k 222,631 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8k 17,631 shares
$0.67
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $267k 205,000 shares
Last Trade
Jan 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 170,000 shares
$0.63
$1.30
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals ZYNE
Chief Legal Officer
Holding Value $260k 200,000 shares
Last Trade
Feb 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$635k 235,000 shares
$2.70
$1.30
OncoCyte
OncoCyte 0KCC.L
COO
Holding Value $57.8k 10,586 shares
Last Trade
Dec 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.46
OncoCyte
OncoCyte 0KCC.L
Chief Operating Officer
Holding Value $27.3k 5,000 shares
Last Trade
Aug 03, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$5.46
OncoCyte
OncoCyte 0KCC.L
Chief Operating Officer
Holding Value $1.11M 204,000 shares
Last Trade
Feb 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.46
OncoCyte
OncoCyte 0KCC.L
Chief Operating Officer
Holding Value $1.09M 200,000 shares
Last Trade
Mar 14, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.46
OncoCyte
OncoCyte 0KCC.L
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Aug 06, 2018 Sale
No data
No data
$5.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up